Neurology Devices Market Size, Share & Trends Analysis Report By Product (Neurostimulation, Interventional Neurology, CSF Management, Spinal Cord Stimulation, Deep Brain Stimulation), By Region, And Segment Forecasts, 2025 - 2030

Neurology Devices Market Growth & Trends

The global neurology devices market size is estimated to reach USD 21.28 billion by 2030, expanding at a CAGR of 8.90% from 2025 to 2030, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.

Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth. According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity. The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.

Neurology Devices Market Report Highlights

  • The rise in home healthcare and remote patient monitoring also fuels the demand for neurology devices
  • The neurostimulation segment accounted for 54.59% of the market revenue in 2024, with spinal cord stimulation devices leading this segment
  • The interventional neurology segment is projected to grow at a CAGR of 10.51% from 2025 to 2030
  • Innovations in coil technology and the introduction of flow diversion devices have significantly improved treatment outcomes, thereby driving market growth
  • North America neurology devices market accounted for 39.70% of the global neurology devices market revenue in 2024, driven by the high prevalence of Neurology disorders and a strong healthcare infrastructure
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of Primary Research
1.5.1. Data for Primary Interviews in North America
1.5.2. Data for Primary Interviews in Europe
1.5.3. Data for Primary Interviews in Asia Pacific
1.5.4. Data for Primary Interviews in Latin America
1.5.5. Data for Primary Interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.1.1. Approach 1: Commodity Flow Approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume Price Analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neurology Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising Prevalence of Neurological Disorders
3.2.1.2. Technological Advancements
3.2.1.3. Increasing Demand for Minimally Invasive Procedures
3.2.1.4. Rising Investment in Research & Development
3.2.2. Market Restraints Analysis
3.2.2.1. High Cost of Devices and Procedures
3.2.2.2. Stringent Regulatory Approvals
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenges Analysis
3.3. Neurology Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining Power of the Suppliers
3.3.1.2. Bargaining Power of the Buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats From New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological Landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
Chapter 4. Neurology Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Neurology Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
4.6. Neurostimulation
4.6.1. Neurostimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Spinal Cord Stimulation
4.6.2.1. Spinal Cord Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Deep Brain Stimulation
4.6.3.1. Deep Brain Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.4. Sacral Nerve Stimulation
4.6.4.1. Sacral Nerve Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Vagus Nerve Stimulation
4.6.5.1. Vagus Nerve Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Gastric Electric Stimulation
4.6.6.1. Gastric Electric Stimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Interventional Neurology
4.7.1. Interventional Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2. Aneurysm Coiling and Embolization
4.7.2.1. Aneurysm Coiling and Embolization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2.2. Embolic Coils
4.7.2.2.1. Embolic Coils Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2.3. Flow Diversion Devices
4.7.2.3.1. Flow Diversion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2.4. Liquid Embolic Reagents
4.7.2.4.1. Liquid Embolic Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.3. Neurovascular Catheters
4.7.3.1. Neurovascular Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.3.2. Micro Catheters
4.7.3.2.1. Micro Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.3.3. Micro Guidewires
4.7.3.3.1. Micro Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4. Cerebral Balloon Angioplasty & Stents
4.7.4.1. Cerebral Balloon Angioplasty & Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4.2. Carotid Artery Stents
4.7.4.2.1. Carotid Artery Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4.3. Filter Devices
4.7.4.3.1. Filter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4.4. Balloon Occlusion Devices
4.7.4.4.1. Balloon Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5. Neurothromobectomy
4.7.5.1. Neurothromobectomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5.2. Clot Retrievers
4.7.5.2.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5.3. Suction Aspiration Devices
4.7.5.3.1. Suction Aspiration Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5.4. Snare Devices
4.7.5.4.1. Snare Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. CSF Management Devices
4.8.1.1. CSF Management Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.2. Cerebral Shunts
4.8.1.2.1. Cerebral Shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.1.3. Cerebral External Drainage
4.8.1.3.1. Cerebral External Drainage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Neurosurgery Devices
4.9.1.1. Neurosurgery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.2. Ultrasonic Aspirators
4.9.1.2.1. Ultrasonic Aspirators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.3. Stereotactic Systems
4.9.1.3.1. Stereotactic Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.4. Neuroendoscopes
4.9.1.4.1. Neuroendoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.1.5. Aneurysm Clips
4.9.1.5.1. Aneurysm Clips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Neurology Devices Market: Regional Estimates & Trend Analysis, By Product
5.1. Regional market share analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2024
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030:
5.6. Neurology Devices Market Share, By Region, 2024 & 2030, USD Million
5.7. North America
5.7.1. North America Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. U.S.
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. Reimbursement Scenario
5.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
5.7.3. Canada
5.7.3.1. Key Country Dynamics
5.7.3.2. Competitive Scenario
5.7.3.3. Regulatory Framework
5.7.3.4. Reimbursement Scenario
5.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
5.7.4. Mexico
5.7.4.1. Key Country Dynamics
5.7.4.2. Competitive Scenario
5.7.4.3. Regulatory Framework
5.7.4.4. Reimbursement Scenario
5.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
5.8. Europe
5.8.1. Europe Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.2. UK
5.8.2.1. Key Country Dynamics
5.8.2.2. Competitive Scenario
5.8.2.3. Regulatory Framework
5.8.2.4. Reimbursement Scenario
5.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
5.8.3. Germany
5.8.3.1. Key Country Dynamics
5.8.3.2. Competitive Scenario
5.8.3.3. Regulatory Framework
5.8.3.4. Reimbursement Scenario
5.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
5.8.4. France
5.8.4.1. Key Country Dynamics
5.8.4.2. Competitive Scenario
5.8.4.3. Regulatory Framework
5.8.4.4. Reimbursement Scenario
5.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
5.8.5. Italy
5.8.5.1. Key Country Dynamics
5.8.5.2. Competitive Scenario
5.8.5.3. Regulatory Framework
5.8.5.4. Reimbursement Scenario
5.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
5.8.6. Spain
5.8.6.1. Key Country Dynamics
5.8.6.2. Competitive Scenario
5.8.6.3. Regulatory Framework
5.8.6.4. Reimbursement Scenario
5.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
5.8.7. Denmark
5.8.7.1. Key Country Dynamics
5.8.7.2. Competitive Scenario
5.8.7.3. Regulatory Framework
5.8.7.4. Reimbursement Scenario
5.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
5.8.8. Sweden
5.8.8.1. Key Country Dynamics
5.8.8.2. Competitive Scenario
5.8.8.3. Regulatory Framework
5.8.8.4. Reimbursement Scenario
5.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
5.8.9. Norway
5.8.9.1. Key Country Dynamics
5.8.9.2. Competitive Scenario
5.8.9.3. Regulatory Framework
5.8.9.4. Reimbursement Scenario
5.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
5.9. Asia Pacific
5.9.1. Asia Pacific Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.2. China
5.9.2.1. Key Country Dynamics
5.9.2.2. Competitive Scenario
5.9.2.3. Regulatory Framework
5.9.2.4. Reimbursement Scenario
5.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
5.9.3. India
5.9.3.1. Key Country Dynamics
5.9.3.2. Competitive Scenario
5.9.3.3. Regulatory Framework
5.9.3.4. Reimbursement Scenario
5.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
5.9.4. Japan
5.9.4.1. Key Country Dynamics
5.9.4.2. Competitive Scenario
5.9.4.3. Regulatory Framework
5.9.4.4. Reimbursement Scenario
5.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
5.9.5. South Korea
5.9.5.1. Key Country Dynamics
5.9.5.2. Competitive Scenario
5.9.5.3. Regulatory Framework
5.9.5.4. Reimbursement Scenario
5.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
5.9.6. Thailand
5.9.6.1. Key Country Dynamics
5.9.6.2. Competitive Scenario
5.9.6.3. Regulatory Framework
5.9.6.4. Reimbursement Scenario
5.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
5.9.7. Australia
5.9.7.1. Key Country Dynamics
5.9.7.2. Competitive Scenario
5.9.7.3. Regulatory Framework
5.9.7.4. Reimbursement Scenario
5.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
5.10. Latin America
5.10.1. Latin America Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10.2. Brazil
5.10.2.1. Key Country Dynamics
5.10.2.2. Competitive Scenario
5.10.2.3. Regulatory Framework
5.10.2.4. Reimbursement Scenario
5.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
5.10.3. Argentina
5.10.3.1. Key Country Dynamics
5.10.3.2. Competitive Scenario
5.10.3.3. Regulatory Framework
5.10.3.4. Reimbursement Scenario
5.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
5.11. Middle East and Africa
5.11.1. Middle East and Africa Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11.2. South Africa
5.11.2.1. Key Country Dynamics
5.11.2.2. Competitive Scenario
5.11.2.3. Regulatory Framework
5.11.2.4. Reimbursement Scenario
5.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
5.11.3. Saudi Arabia
5.11.3.1. Key Country Dynamics
5.11.3.2. Competitive Scenario
5.11.3.3. Regulatory Framework
5.11.3.4. Reimbursement Scenario
5.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
5.11.4. UAE
5.11.4.1. Key Country Dynamics
5.11.4.2. Competitive Scenario
5.11.4.3. Regulatory Framework
5.11.4.4. Reimbursement Scenario
5.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
5.11.5. Kuwait
5.11.5.1. Key Country Dynamics
5.11.5.2. Competitive Scenario
5.11.5.3. Regulatory Framework
5.11.5.4. Reimbursement Scenario
5.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors
6.3.2. Key Company Market Share Analysis, 2024
6.4. Key Company Profiles
6.4.1. Medtronic
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Johnson and Johnson Services Inc.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Penumbra, Inc.
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. Microport Scientific Corporation
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Stryker
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Microvention Inc (Terumo Corporation)
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Codman Neuro (Integra Lifesciences)
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Abbott
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. Boston Scientific Corporation
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. Nexstim
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. LivaNova PLC
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Neuropace Inc.
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
6.4.13. electroCore, Inc.
6.4.13.1. Participant’s Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Recent Developments/ Strategic Initiatives
6.4.14. Axonics, Inc.
6.4.14.1. Participant’s Overview
6.4.14.2. Financial Performance
6.4.14.3. Product Benchmarking
6.4.14.4. Recent Developments/ Strategic Initiatives
6.4.15. Zimmer Biomet
6.4.15.1. Participant’s Overview
6.4.15.2. Financial Performance
6.4.15.3. Product Benchmarking
6.4.15.4. Recent Developments/ Strategic Initiatives
6.4.16. Brain lab AG
6.4.16.1. Participant’s Overview
6.4.16.2. Financial Performance
6.4.16.3. Product Benchmarking
6.4.16.4. Recent Developments/ Strategic Initiatives
6.4.17. Acandis GmbH
6.4.17.1. Participant’s Overview
6.4.17.2. Financial Performance
6.4.17.3. Product Benchmarking
6.4.17.4. Recent Developments/ Strategic Initiatives
6.4.18. Söring GmbH
6.4.18.1. Participant’s Overview
6.4.18.2. Financial Performance
6.4.18.3. Product Benchmarking
6.4.18.4. Recent Developments/ Strategic Initiatives
6.4.19. CooperSurgical Inc.
6.4.19.1. Participant’s Overview
6.4.19.2. Financial Performance
6.4.19.3. Product Benchmarking
6.4.19.4. Recent Developments/ Strategic Initiatives

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings